Ishiguro H - Search Results

1

Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer.

Uemura H, Hasumi H, Kawahara T, Sugiura S, Miyoshi Y, Nakaigawa N, Teranishi J, Noguchi K, Ishiguro H, Kubota Y. Uemura H, et al. Among authors: ishiguro h. Int J Clin Oncol. 2005 Dec;10(6):405-10. doi: 10.1007/s10147-005-0520-y. Int J Clin Oncol. 2005. PMID: 16369744 Clinical Trial.

2

Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.

Fujinami K, Uemura H, Ishiguro H, Kubota Y. Fujinami K, et al. Among authors: ishiguro h. Int J Mol Med. 2002 Aug;10(2):173-6. Int J Mol Med. 2002. PMID: 12119554

3

[A novel molecular target therapeutics for refractory prostate cancer].

Uemura H, Ikeda N, Nakaigawa N, Ouchi H, Ishiguro H, Kubota Y. Uemura H, et al. Among authors: ishiguro h. Nihon Rinsho. 2002 Dec;60 Suppl 11:272-7. Nihon Rinsho. 2002. PMID: 12599584 Review. Japanese. No abstract available.

4

55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor.

Ishiguro H, Uemura H, Fujinami K, Ikeda N, Ohta S, Kubota Y. Ishiguro H, et al. Int J Cancer. 2003 May 20;105(1):26-32. doi: 10.1002/ijc.11021. Int J Cancer. 2003. PMID: 12672026

5

Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.

Miyoshi Y, Ishiguro H, Uemura H, Fujinami K, Miyamoto H, Miyoshi Y, Kitamura H, Kubota Y. Miyoshi Y, et al. Among authors: ishiguro h. Prostate. 2003 Sep 1;56(4):280-6. doi: 10.1002/pros.10262. Prostate. 2003. PMID: 12858356

6

Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells.

Ikeda N, Uemura H, Ishiguro H, Hori M, Hosaka M, Kyo S, Miyamoto K, Takeda E, Kubota Y. Ikeda N, et al. Among authors: ishiguro h. Mol Cancer Ther. 2003 Aug;2(8):739-46. Mol Cancer Ther. 2003. PMID: 12939463

7

Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor.

Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, Sakaguchi A, Kubota Y. Uemura H, et al. Among authors: ishiguro h. Mol Cancer Ther. 2003 Nov;2(11):1139-47. Mol Cancer Ther. 2003. PMID: 14617787

8

Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.

Ouchi H, Ishiguro H, Ikeda N, Hori M, Kubota Y, Uemura H. Ouchi H, et al. Among authors: ishiguro h. Int J Urol. 2005 Jan;12(1):73-80. doi: 10.1111/j.1442-2042.2004.00973.x. Int J Urol. 2005. PMID: 15661057

9

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

Ishiguro H, Nakaigawa N, Miyoshi Y, Fujinami K, Kubota Y, Uemura H. Ishiguro H, et al. Prostate. 2005 Jun 15;64(1):92-100. doi: 10.1002/pros.20219. Prostate. 2005. PMID: 15666359

10

Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.

Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, Hamada K, Inayama Y, Kishida T, Hattori K, Yamada-Okabe H, Kubota Y. Yao M, et al. Among authors: ishiguro h. J Pathol. 2005 Feb;205(3):377-87. doi: 10.1002/path.1693. J Pathol. 2005. PMID: 15682440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

925 results

Search Page

Filters